Abstract
(Am J Obstet Gynecol. 2020;222:259.e1–259.e11) There is a clear need for quantitative testing methods to determine which patients with signs of preeclampsia may be at heightened risk for adverse pregnancy outcomes. The altered angiogenic factor concentrations including placental growth factor (PlGF) have been found to be associated with preeclampsia and precede the onset of preeclampsia by several weeks. While previous studies have found encouraging evidence that PlGF concentrations may predict adverse pregnancy outcomes, the association between angiogenic factors and time to delivery (TTD) is still unclear. This study aimed to examine the relationship between TTD and PlGF in pregnant women with gestational age <35 weeks with signs of preeclampsia and to evaluate the performance of PlGF as a predictor for TTD.
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
